Ga-68 MAA Distribution in PAE Patients

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Gallium 68 Macro-aggregated albumin

The radiotracer, Ga-68 MAA, will be administered prior to PET/MRI scan.

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BTG International Inc.

OTHER

collaborator

Embolx, Inc.

UNKNOWN

lead

University of North Carolina, Chapel Hill

OTHER